Panacea Biotec
Ticker > Company >

Panacea Biotec share price

Panacea Biotec Ltd.

NSE: PANACEABIO BSE: 531349 SECTOR: Pharmaceuticals & Drugs  43k   106   23

410.95
+15.35 (3.88%)
BSE: Today, 12:56 PM

Price Summary

Today's High

₹ 415.35

Today's Low

₹ 380.15

52 Week High

₹ 398.95

52 Week Low

₹ 112.7

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 2517.1 Cr.

Enterprise Value

₹ 2612.53 Cr.

No. of Shares

6.13 Cr.

P/E

0

P/B

7.95

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  51.69

CASH

₹ 29.44 Cr.

DEBT

₹ 124.87 Cr.

Promoter Holding

72.87 %

EPS (TTM)

₹  -2.19

Sales Growth

39.89%

ROE

1.08 %

ROCE

4.08%

Profit Growth

104.06 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year39.89%
3 Year1.53%
5 Year-4.14%

Profit Growth

1 Year104.06%
3 Year30.96%
5 Year-33.14%

ROE%

1 Year1.08%
3 Year-14.27%
5 Year-13.77%

ROCE %

1 Year4.08%
3 Year-7.81%
5 Year-4.61%

Debt/Equity

0.3794

Price to Cash Flow

67.53

Interest Cover Ratio

1.3052

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 72.87 0.00
Jun 2024 73.46 0.00
Mar 2024 73.59 0.00
Dec 2023 73.59 0.00
Sep 2023 73.59 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 30.9653078835458% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of -199.0808 days.
  • The company has a high promoter holding of 72.87%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 18.6757297423944.

 Limitations

  • The company has shown a poor revenue growth of 1.53349770699727% for the Past 3 years.
  • Company has a poor ROE of -14.274393209569% over the past 3 years.
  • Company has a poor ROCE of -7.80721170480353% over the past 3 years
  • Company has contingent liabilities of 369.385 Cr.
  • The company has a low EBITDA margin of -9.78410222312693% over the past 5 years.
  • The company is trading at a high PE of 0.
  • The company is trading at a high EV/EBITDA of 128.4051.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 94.59 95.23 80.37 56.88 76.64
Total Expenditure 84.63 88.59 89.61 67.37 69.9
Operating Profit 9.96 6.64 -9.24 -10.49 6.74
Other Income 2.13 3.05 16.39 3.8 3.41
Interest 3.55 3.41 3.36 3.21 3.76
Depreciation 5.34 5.21 5.14 5.08 5.09
Exceptional Items 0 0 0 0 0
Profit Before Tax 3.2 1.07 -1.35 -14.98 1.3
Tax 0 0.64 0.02 -1.2 0.01
Profit After Tax 3.2 0.43 -1.37 -13.78 1.29
Adjusted EPS (Rs) 0.52 0.07 -0.22 -2.25 0.21

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 489.68 343.56 235.5 257.07 359.6
Total Expenditure 479.63 343.07 308.17 319.69 345.44
Operating Profit 10.05 0.49 -72.67 -62.63 14.17
Other Income 43.91 20.75 12.57 34.44 24.91
Interest 147.25 7.52 7.04 10.06 13.78
Depreciation 27.29 26.57 26.43 24.5 21.09
Exceptional Items -15.4 0 0 0 0
Profit Before Tax -135.97 -12.85 -93.58 -62.75 4.21
Tax 17.1 1.56 0 24.79 0.66
Net Profit -153.07 -14.44 -93.58 -87.54 3.55
Adjusted EPS (Rs.) -24.99 -2.35 -15.28 -14.29 0.58

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 6.13 6.13 6.13 6.13 6.13
Total Reserves 886.61 502.04 408.97 319.53 323.02
Borrowings 60.43 62.08 84.1 102.4 124.87
Other N/C liabilities 186.72 191.99 187.36 214.38 222.12
Current liabilities 167.35 197.67 244.16 250.85 248.99
Total Liabilities 1307.23 961.76 933.31 895.38 925.12
Assets
Net Block 447.29 398.44 416.13 385.31 357.26
Capital WIP 3.66 12.93 0.86 16.42 70.8
Intangible WIP 0.08 0.04 0.01 11.42 25.74
Investments 2.55 0.27 0.27 0.27 0.27
Loans & Advances 186.5 187.45 188.82 225.33 221.39
Other N/C Assets 52.84 106.82 78.38 57.48 66.46
Current Assets 614.32 255.8 248.83 199.13 183.2
Total Assets 1307.23 961.76 933.31 895.38 925.12
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -135.97 -12.88 -93.58 -62.75 4.21
Adjustment 204.95 31.82 35.98 10.43 30.95
Changes in Assets & Liabilities -143.93 20.3 5.73 42.67 4
Tax Paid -7.9 -0.98 -0.82 -1.09 -1.88
Operating Cash Flow -82.86 38.27 -52.69 -10.74 37.27
Investing Cash Flow -16.58 -37.32 39.54 2.41 -51.01
Financing Cash Flow 109.39 -7.2 9.83 9.01 12.82
Net Cash Flow 9.96 -6.26 -3.32 0.67 -0.91

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 73.59 73.59 73.59 73.46 72.87
dr. rajesh jain 49.33 49.33 49.33 49.33 49.33
first lucre partnership c... 3.68 3.68 3.68 3.68 3.68
mr. sandeep jain 16.38 16.38 16.38 16.25 15.66
mrs. nirmala jain 4.10 4.10 4.10 4.10 4.10
second lucre partnership ... 0.09 0.09 0.09 0.09 0.09
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 26.41 26.41 26.41 26.54 27.13
investor education and pr... - - - - 0.17
magic square hospitality ... - - - - 2.68
investor education and pr... 0.17 0.17 0.17 0.17 -
serum institute of india ... 1.10 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Panacea Biotec informs about press release 12 Sep, 5:00 PM Panacea Biotec informs about disclosures 9 Sep, 2:25 PM Panacea Biotec informs about disclosure 20 Aug, 12:09 PM Panacea Biotec informs about newspaper publication 16 Aug, 12:30 PM Panacea Biotec - Quaterly Results 14 Aug, 4:25 PM Panacea Biotec’s arm incorporates wholly-owned subsidiary in USA 24 Jun, 9:59 AM Panacea Biotec informs about demat status report 7 Jun, 4:46 PM Panacea Biotec - Quaterly Results 30 May, 2:22 PM Panacea Biotec informs about details of shares dematerialized 5 Apr, 4:50 PM Panacea Biotec informs about newspaper publication 13 Mar, 5:07 PM Panacea Biotec informs about notice of postal ballot 12 Mar, 5:19 PM Panacea Biotec - Quaterly Results 13 Feb, 2:50 PM Panacea Biotec - Quaterly Results 13 Feb, 2:50 PM Panacea Biotec - Quaterly Results 13 Feb, 2:50 PM Panacea Biotec informs about board meeting 30 Jan, 4:41 PM Panacea Biotec launches fully-liquid wP-IPV based Pentavalent vaccine ‘EasyFourPol’ 14 Dec, 6:16 PM Panacea Biotec’s arm launches Paclitaxel Protein-Bound Particles for Injectable Suspension 28 Oct, 11:33 AM Panacea Biotec informs about updates 28 Oct, 10:36 AM USFDA concludes inspection at Baddi facility of Panacea Biotec’s arm 13 Oct, 10:09 AM Panacea Biotec informs about disclosure 12 Sep, 5:26 PM Panacea Biotec informs about BRSR 7 Sep, 4:53 PM Panacea Biotec informs about shares dematerialized 6 Sep, 12:37 PM Panacea Biotec - Quaterly Results 12 Aug, 3:17 PM Panacea Biotec - Quaterly Results 12 Aug, 3:17 PM Panacea Biotec informs about launch of news products 15 Jun, 2:24 PM Panacea Biotec’s arm launches new range of pediatric food & nutritional products 15 Jun, 11:40 AM Panacea Biotec - Quaterly Results 30 May, 2:53 PM Panacea Biotec informs about closure of trading window 30 Mar, 11:21 AM Panacea Biotec - Quaterly Results 14 Feb, 1:43 PM Panacea Biotec - Quaterly Results 14 Feb, 1:43 PM Panacea Biotec - Quaterly Results 14 Feb, 1:43 PM Panacea Biotec donates 125,000 SDVs to Cuba 17 Jan, 12:50 PM Panacea Biotec informs about disclosure of related party transactions 29 Nov, 3:43 PM Panacea Biotec - Quaterly Results 14 Nov, 4:54 PM Panacea Biotec - Quaterly Results 14 Nov, 4:54 PM Panacea Biotec gets UNICEF, PAHO awards for supply of Pentavalent Vaccine 11 Oct, 9:38 AM Panacea Biotec - Quaterly Results 9 Aug, 3:30 PM Panacea Biotec - Quaterly Results 9 Aug, 3:30 PM Panacea Biotec informs about postal ballot notice 28 Jun, 5:14 PM Panacea Biotec informs about disclosure 10 Jun, 2:24 PM USFDA conducts inspection at Panacea Biotec’s arm’s facility at Baddi 10 Jun, 9:47 AM Panacea Biotec - Quaterly Results 18 May, 3:01 PM Panacea Biotec - Quaterly Results 18 May, 3:01 PM Panacea Biotec - Quaterly Results 18 May, 3:01 PM Panacea Biotec informs about appointment of additional director 2 Apr, 11:47 AM Panacea Biotec informs about resignation of director 10 Mar, 4:32 PM Panacea Biotec - Quaterly Results 14 Feb, 4:16 PM Panacea Biotec - Quaterly Results 14 Feb, 4:16 PM Panacea Biotec supplies first shipment of second component of Sputnik V vaccine produced in India 7 Sep, 9:28 AM Panacea Biotec informs about newspaper advertisement 26 Jul, 3:48 PM

Panacea Biotec Stock Price Analysis and Quick Research Report. Is Panacea Biotec an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Panacea Biotec and its performance over the period of time. Panacea Biotec stock price today is Rs 406.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Panacea Biotec cash from the operating activity was Rs 37.273 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Panacea Biotec has a Debt to Equity ratio of 0.3794 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Panacea Biotec , the EPS growth was 104.0552 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Panacea Biotec has OPM of 3.93961135026306 % which is a bad sign for profitability.
     
  • ROE: Panacea Biotec have a poor ROE of 1.0843 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Panacea Biotec is Rs 406. One can use valuation calculators of ticker to know if Panacea Biotec share price is undervalued or overvalued.
Last Updated on:
Brief about Panacea Biotec

Panacea Biotec Limited Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Panacea Biotec Limited is a leading biotechnology company based in India. With a focus on healthcare and pharmaceuticals, the company has a strong presence in research, development, manufacturing, and marketing of vaccines, generics, and biopharmaceuticals. Panacea Biotec Limited aims to provide affordable healthcare solutions for patients around the world.

Panacea Biotec Limited - Share Price

Stay updated on the latest share price of Panacea Biotec Limited by visiting our stock analysis page. Our website provides real-time stock prices, allowing investors to track the performance of the company's shares.

Panacea Biotec Limited - Balance Sheet

To gain insight into the financial position of Panacea Biotec Limited, utilize our pre-built screening tools available on our website. These tools enable long-term stock investors to analyze the company's balance sheet. Additionally, through our premium features, investors can make use of fair value calculation tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis.

Panacea Biotec Limited - Annual Report

The annual reports of Panacea Biotec Limited can be found as downloadable documents on our website. These reports provide comprehensive information about the company's performance, financials, operational highlights, and future prospects. Long-term stock investors can closely examine these reports to make informed investment decisions.

Panacea Biotec Limited - Dividend

For dividend analysis of Panacea Biotec Limited, our website provides access to dividend data and historical records. Investors can evaluate the company's dividend history to understand its dividend-paying practices and assess the potential income generated from their investments.

Panacea Biotec Limited - Quarterly Results

Along with the annual reports, we offer quarterly results of Panacea Biotec Limited for download on our website. These reports give investors a timely overview of the company's performance during specific quarters. Combined with our premium features, investors can use various analysis tools to gain deeper insights into the company's financial health.

Panacea Biotec Limited - Stock Price

On our website, you can find the latest stock prices of Panacea Biotec Limited, enabling you to closely monitor the price movements of the company's shares. Stay updated with real-time price data to make well-informed investment decisions.

Panacea Biotec Limited - Price Chart

Utilize the price charts available on our website to visualize the historical price movements of Panacea Biotec Limited's stocks. These charts help investors identify patterns and trends, enabling them to make more accurate predictions about future stock performance.

Panacea Biotec Limited - News

For the latest company news and updates about Panacea Biotec Limited, visit our website. Stay informed about significant developments, such as product launches, regulatory approvals, collaborations, and acquisitions, which may impact the company's stock performance.

Panacea Biotec Limited - Concall Transcripts

At our website, we provide downloadable concall transcripts of Panacea Biotec Limited. These transcripts contain records of the company's conference calls with analysts and investors, showcasing discussions on various aspects of the company's performance, strategies, and future plans.

Panacea Biotec Limited - Investor Presentations

Gain a deeper understanding of Panacea Biotec Limited's business strategies, growth plans, and market positioning by accessing investor presentations on our website. These presentations provide valuable insights into the company's operations, performance highlights, and future outlook.

Panacea Biotec Limited - Promoters

Panacea Biotec Limited is driven by a team of dedicated promoters who are professionals in the field of biotechnology and healthcare. Our website provides detailed information about the company's promoters, their expertise, and their contributions towards the company's growth.

Panacea Biotec Limited - Shareholders

Discover the major shareholders of Panacea Biotec Limited on our website. We offer insights into institutional investors and their holdings, helping investors understand the ownership structure of the company and its potential impact on stock performance.

By utilizing our website's comprehensive stock analysis tools and accessing downloadable reports, transcripts, and presentations, long-term stock investors can perform a detailed analysis of Panacea Biotec Limited. Stay informed, make informed investment decisions, and potentially benefit from the growth and prospects of this leading biotechnology company.

Read More
X